{
  "docId": "019de075-12bd-74a7-bc75-4587e4948a57",
  "docSlug": "9c54f748d4238e6a3a690a4101a45e99",
  "documentTitle": "Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "deck",
  "documentKindLabel": "Deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 42,
  "pageCount": 50,
  "prevPage": 41,
  "nextPage": 43,
  "slideType": "problem_statement",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a Venn diagram to illustrate target overlap and a hierarchical tree to show potential combination therapy paths.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-12bd-74a7-bc75-4587e4948a57/42",
  "deckHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57",
  "deckJsonHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57.json",
  "deckAnchorHref": "/decks/019de075-12bd-74a7-bc75-4587e4948a57#slide-42",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.65,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Precision immunology hierarchy showing monotherapies and combinations",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f763acba-ae7b-4955-9a13-36b3a64c75f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Circular process showing TNF, a4b7, and IL-23 cycle",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "447385a7-4de9-44b7-a367-795c3329e5b9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Venn diagram of TL1A, IL-23, and a4b7",
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e055d56-ae17-4df2-a4fb-b2ba832b8eb9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.25,
        "x": 0.03,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "IBD patients cycle though multiple biologics with modest remission rates",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c993d460-6fe5-440f-9f8c-d02542a34c8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.65,
        "x": 0.29,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "We believe the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d284075e-db90-4ea0-98ec-ad535759bd15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "We aim to develop companion diagnostics to augment our therapeutic combinations and monotherapies",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d421e4d-ad7d-4384-9ba8-9e1939744441",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "8f54443e-9d6a-4a6d-ad44-23dd3acb9820",
      "evidence": "paragraph/paragraph: We believe the future of IBD includes combination therapies and precision approaches to break the therapeutic ceiling",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "precision-medicine-strategy",
      "slug": null,
      "matchId": "2d6306e4-9d1d-4d69-a3d1-b05e2e33e560",
      "evidence": "The slide maps specific biological targets to combination therapy paths.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}